WBH Advisory Inc. Sells 155 Shares of Agilent Technologies, Inc. (NYSE:A)

WBH Advisory Inc. lowered its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 9.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,561 shares of the medical research company’s stock after selling 155 shares during the period. WBH Advisory Inc.’s holdings in Agilent Technologies were worth $202,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in A. CX Institutional raised its holdings in shares of Agilent Technologies by 15.1% in the 2nd quarter. CX Institutional now owns 3,020 shares of the medical research company’s stock worth $391,000 after buying an additional 397 shares in the last quarter. Guinness Asset Management LTD raised its stake in Agilent Technologies by 3.3% during the second quarter. Guinness Asset Management LTD now owns 3,669 shares of the medical research company’s stock worth $476,000 after acquiring an additional 118 shares in the last quarter. Park Avenue Securities LLC lifted its holdings in shares of Agilent Technologies by 9.3% during the second quarter. Park Avenue Securities LLC now owns 13,101 shares of the medical research company’s stock valued at $1,698,000 after acquiring an additional 1,116 shares during the period. Kingswood Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies in the 2nd quarter valued at $273,000. Finally, Fulton Bank N.A. grew its holdings in shares of Agilent Technologies by 1.5% in the 2nd quarter. Fulton Bank N.A. now owns 9,907 shares of the medical research company’s stock worth $1,284,000 after purchasing an additional 148 shares during the last quarter. 87.42% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A has been the topic of a number of research analyst reports. TD Cowen restated a “buy” rating and set a $153.00 price target on shares of Agilent Technologies in a research report on Monday, July 29th. JPMorgan Chase & Co. decreased their target price on Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Stifel Nicolaus cut their price target on Agilent Technologies from $163.00 to $151.00 and set a “buy” rating for the company in a report on Thursday, May 30th. Evercore ISI raised their price objective on shares of Agilent Technologies from $126.00 to $130.00 and gave the company an “in-line” rating in a research report on Tuesday, July 2nd. Finally, Barclays decreased their price target on shares of Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating on the stock in a research note on Friday, May 31st. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $138.06.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the sale, the senior vice president now owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, SVP Dominique Grau sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the sale, the senior vice president now owns 49,486 shares in the company, valued at $6,595,494.08. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the transaction, the chief executive officer now owns 25,185 shares in the company, valued at approximately $3,274,050. The disclosure for this sale can be found here. Insiders have sold 18,916 shares of company stock worth $2,527,860 over the last 90 days. Company insiders own 0.33% of the company’s stock.

Agilent Technologies Stock Down 0.1 %

Shares of A traded down $0.07 during mid-day trading on Friday, hitting $136.69. 40,631 shares of the company’s stock were exchanged, compared to its average volume of 1,766,680. The company has a market cap of $39.88 billion, a PE ratio of 32.33, a P/E/G ratio of 4.86 and a beta of 1.05. Agilent Technologies, Inc. has a 52 week low of $96.80 and a 52 week high of $155.35. The company has a 50-day simple moving average of $132.64 and a 200 day simple moving average of $138.01. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.15 and a quick ratio of 1.64.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.03. The business had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.58 billion. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. Agilent Technologies’s revenue was down 8.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.27 earnings per share. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd were paid a $0.236 dividend. The ex-dividend date was Tuesday, July 2nd. This represents a $0.94 annualized dividend and a yield of 0.69%. Agilent Technologies’s dividend payout ratio is 22.22%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.